References
Renard E, Schaepelynck-Bélicar P, EVADIAC Group (2007) Implantable insulin pumps: a position statement about their clinical use. Diabetes Metab 33:158–166
Garcia-Verdugo R, Erbach M, Schnell O (2017) A new optimized percutaneous access system for CIPII. J Diabetes Sci Technol 11(4):814–821
Shapiro AM, Pokrywczynska M, Ricordi C (2017) Clinical pancreatic islet transplantation. Nat Rev Endocrinol 13(5):268–277
Radermecker RP, Renard E, Scheen AJ (2009) Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control. Diabetes Metab Res Rev 25(6):491–501
Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Gans RO, Bilo HJ (2010) Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: a randomised controlled trial. Diabetes Care 33:1169–1172
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests for this manuscript.
Ethical statement
The patient agreed to the description of her clinical story, anonymously.
Informed consent
The patient has given her informed consent for the case report to be published, preserving anonymity.
Additional information
Managed by Antonio Secchi.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pasquini, S., Da Prato, G., Tonolo, G. et al. Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes. Acta Diabetol 57, 101–104 (2020). https://doi.org/10.1007/s00592-019-01398-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-019-01398-3